21st Century Drug Discovery and Development for Global Health
The conference is part of the Keystone Symposia Global Health Series and is supported by the Bill & Melinda Gates Foundation.
Session
New therapeutics for global health
Date: Thursday, 18 October 2018
Time: 8:30-10:00
Location: Bordeaux I-II
Transformative new therapies for Human African trypanosomiasis |
Progress with cipargamin and KAF156 in phase 2 development for treatment of malaria |
Novel drug candidates to address the threat of antibacterial resistance in the developing world; TB and Shigella |
Importance of chemical diversity in seeking new leads
Date: Friday, 19 October 2018
Time: 8:30-11:30
Location: Bordeaux I-II
Experience with DNA-encoded libraries in search for new leads against TB and malaria Ghotas Evindar, Manager and ELT Hit to Lead Group Leader, GlaxoSmithKline, USA |
Application of data-mining and deep learning to identify new leads from marine natural products |
Identifying anti-filarial candidates using a multi-faceted screening funnel |
| A new era of orally active treatments for leishmaniasis patients Charles Mowbray, Discovery Director, DNDi, Switzerland |
More information:
